FDA issues draft guidance on developing weight loss drugs

Editor’s note: This article was updated at 145p ET with comment from Evercore ISI analyst Umer Raffat.

The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity.

The new document